Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb;11(2):339–357. doi: 10.21037/tcr-21-1841

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2022 Translational Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

PMC Copyright notice

The prognostic value of different expressed drug resistance-related genes in LUSC patients in the OS curve (GEPIA). The overall survival curve of CCDC73 (A), DLGAP1 (B), DSEL (C), ESR1 (D), and SEC14L5 (E) in LUSC. HR, hazard ratio; TPM, transcript per million; LUSC, lung squamous cell carcinoma; OS, overall survival; CCDC73, coiled-coil domain-containing protein 73; DLGAP1, DLG associated protein 1; DSEL, dermatan sulfate epimerase like; ESR1, estrogen receptor 1; SEC14L5, SEC14-like 5.